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Abstract: The efficacy of boric acid (BA) was examined on liver marker enzymes in aluminum (Al)-treated rats. Also,
a liver micronucleus assay was performed to evaluate the genotoxicity in hepatocytes. With these aims, SpragueDawley rats were randomly separated into 10 groups of 5 animals. Aluminum chloride (5 mg/kg body weight (b.w.)
AlCl3) and BA (3.25, 13, 36 and 58.5 mg/kg b.w.) alone were administered with injections to the experimental animals.
Furthermore, the animals were also treated with Al for 4 consecutive days followed by BA exposure for 10 days. The
rats were anesthetized after Al and BA injections and the levels of serum enzymes were determined. Hepatocytes were
isolated for counting the number of micronucleated hepatocytes (MNHEPs). After exposure to Al, the enzymatic
activities of alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and
lactate dehydrogenase (LDH) significantly increased. Furthermore, this metal caused a significant increase in MNHEPs’
incidence. In contrast, the applications of BA doses did not cause any adverse effect on the above parameters. Moreover,
pretreatments with BA significantly modulated the toxic effects of Al.
Key words: Aluminum, boric acid, liver, micronucleus assay, rat, serum enzymes

Sıçanda alüminyum ile uyarılmış hepatotoksisite ve genotoksisite
üzerine borik asidin koruyucu etkisi
Özet: Bu çalışmada, alüminyum ile muamele edilmiş sıçanlarda borik asitin (BA) karaciğer markör enzimleri üzerine
etkisi incelendi. Ayrıca hepatositlerde genotoksiste değerlendirmesi için karaciğer mikronukleus testi uygulandı. Bu
amaçlarla, Sprague-Dawley sıçanları rastgele on gruba ayrıldı ve her bir grupta beş hayvan yeraldı. Alüminyum klorid
(5 mg/kg vücut ağırlığı (v.a.) AlCl3) ve borik asit (3,25, 13, 36 and 58,5 mg/kg v.a.) tek başlarına injeksiyonlar ile deney
hayvanlarına verildi. Bunun yanı sıra, on günlük BA maruz kalmayı takiben dört gün boyunca da hayvanlar alüminyum
ile muamele edildi. Alüminyum ve BA enjeksiyonundan sonra bayıltılmış sıçanlardan alınan kanlarda serum enzim
düzeyleri tespit edildi. Mikronukleuslu hepatositlerin (MNHEPs) sayısını hesaplamak için de hepatositler izole edildi.
Alüminyuma maruz kalmayı takiben, alkalin fosfataz (ALP), aspartat aminotransferaz (AST), alanin aminotransferaz
(ALT) ve laktat dehidrojenaz (LDH) enzim aktiviteleri belirgin olarak yükseldi. Ayrıca, bu metal MNHEPs oranında
belirgin bir yükselmeye neden oldu. Aksine, BA dozlarının uygulanması yukardaki parametreler üzerinde herhangi bir
olumsuz etkiye sebep olmadı. Üstelik BA ile ön muameleler alüminyumun toksik etkilerini düşürdü.
Anahtar sözcükler: Alüminyum, borik asit, karaciğer, mikronukleus testi, sıçan, serum enzimleri
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Introduction
Aluminum (Al) is the third most common
element on the Earth’s crust. The almost ubiquitous
presence of Al has so heavily contaminated our
environment that exposure is virtually inescapable
(1). The extensive use of this metal (food and
occupational exposure) was questioned due to its
toxic effects (2). Moreover, Al toxicity occurred as
a result of aluminum containing pharmaceutical
products such as aluminum based phosphate
binders or antacid intake (3). Al has pro-oxidative
effects in vitro and in vivo (4). Thus, Al provoked
cardiotoxicity, nephrotoxicity, and neurotoxicity
(3,5). Furthermore, Al induced hepatic dysfunctions,
DNA cross-linking in rat ascites hepatoma cells (6),
MN and sister chromatid exchange (SCE) formations
in human peripheral blood lymphocytes (7-10).
Boron is a trace mineral for plants, animals, and
humans (11). It probably strengthens the antioxidant
defense mechanism by a yet unknown mechanism
(12). Research findings suggest that physiological
amounts of supplemental dietary boron affect a wide
range of metabolic parameters in animals (13). It is
released in the form of BA that is water soluble and
biologically available. BA is found in an array of
consumer goods including fireproofing for fabrics
and wood, insecticides, and in many cosmetics and
personal care products as well (14). It is absorbed
from the gastrointestinal tract into the blood stream
(15) and plays an important role in improving
arthritis, plasma lipid profiles, and brain function
(11,16). Boronated agents with hypolipidemic, antiinflammatory, or anticancer properties are also
developed (16). Short-term mutagenicity studies
clearly revealed that boron compounds are not
genotoxic. BA was found negative for mutagenicity in
the Escherichia coli Sd-4 and Salmonella typhimurium
assays (17,18). Moreover, results in mammalian
genotoxicity test systems were all negative. BA was
negative in inducing unscheduled DNA synthesis
in cultured rat hepatocytes (19) and did not
induce forward mutations in mouse lymphoma
cells (18,20). Similarly, borax and borax ores were
found to be negative in assays for mutagenicity in
Chinese hamster cells, mouse embryo fibroblasts,
and human foreskin fibroblasts (21). BA did not
induce chromosome aberrations (CAs) or increase
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the frequency of SCEs in Chinese hamster ovary
(CHO) cells (18). BA did not induce chromosomal
or mitotic spindle abnormalities in bone marrow
erythrocytes in the MN assay in Swiss-Webster
mice (22). Besides these findings, BA did not alter
the incidence of SCEs over control cells (23,24) but
induced structural and total CAs (24). It was also
determined that boron mines did not have genotoxic
and carcinogenic effects on boron miners and did not
increase chromosomal anomalies (25). Therefore, BA
remains a very interesting research topic due to its
equivocal and relatively unknown useful action, role
in the treatment of various diseases, and interactions
with other elements.
The liver is a critical organ that contains most of
the accumulated metals and where toxic effects can
be expected (26,27). Al accumulated higher in the
liver than in the brain, muscle, heart, or lung (28).
Hence, in recent years, it has become especially
important to examine useful antidotes against the
toxic effects of Al. The supplementation with free
radical scavengers (e.g. BA) may protect animals
from the harmful effect of Al. The role of BA in liver
against aluminum-induced changes has not so far
been studied. Usually, the extent of hepatic damage is
assessed by the increased level of cytosolic enzymes
such as ALT, AST, and ALP (29,30). Liver MN assays
are particularly useful for the detection of the in vivo
genotoxic effects of many chemicals by providing
the necessary metabolic activation pathways (31). In
this study, our major goal was to elucidate the in vivo
potential protective role of BA against Al-induced
hepatotoxicity and genotoxicity in rats. Thus, here we
focused on changes in serum enzymes as a marker
associated with hepatic dysfunction and alterations
in MN formations in hepatocytes as genotoxic
endpoint. With these aims, the present study was
designed to determine levels of liver enzymes and
rate of MNHEPs formations in rats after exposure to
3.25, 13, 36, and 58.5 mg/kg b.w. concentrations of
BA and 5 mg/kg b.w. AlCl3.
Materials and methods
Animals
The experiment was carried out on male SpragueDawley rats, 8 weeks old, weighing 150-200 g. The
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animals were kept on a 12-h light-dark cycle and
allowed free access to food and water. All experiments
were performed in accordance with the Guide for the
Care and Use of Laboratory Animals (32).
Experimental design
The animals were randomly divided into 10
groups: (1) controls, which were intact with no
previous experimental history; (2) rats that received
5 mg/kg b.w. AlCl3 (CAS No. 7784-13-6, Merck®)
injection intraperitoneally (ip) for 4 days; (3, 4, 5,
and 6) rats that received 3.25, 13, 36, and 58.5 mg/
kg b.w. BA (CAS No. 10043-35-3, Sigma®) ip for 10
days; (7, 8, 9, and 10) rats were treated with AlCl3
for 4 consecutive days followed by different doses
of BA exposure for 10 days. The doses were selected
according to the literature data (33-35). There were
5 rats in each group. After the following injections
of all chemicals, the animals were anesthetized with
ether.
Biochemical studies
Blood samples were collected into serum separator
tubes (Microtainer; Becton Dickinson, Franklin
Lakes, NJ, USA), allowed to stand (75-90 min),
centrifuged (3000 rpm, 5 min), serum harvested,
and stored at –20 °C. The following parameters
were measured by an automated biochemical
analyzer (Olympus AU 2700) with Bayer testing kits
(Bioclinica): ALP, AST, ALT, and LDH.
Liver MN assay
The liver MN assay was done by using the method
of Suzuki et al. (31). Isolated hepatocytes from
rats were prepared by the collagenase perfusion
technique (36). The liver was perfused through
the hepatic portal vein with calcium-free Hanks
balanced salt solution to remove blood for about
10 min at a flow rate of 2.5 mL/min. As soon as the
liver became grayish brown in color, a second buffer
solution containing collagenase (Hank’s balanced salt
supplemented with 4 mM calcium chloride and 0.5
mg collagenase/mL) was perfused at the same rate
until the liver appeared to have broken up. Then the
liver minced into 3- to 4-mm pieces with a sterile
scalpel. Following mechanical dissociation, the cells
were filtered through gauze and centrifuged at 1350
rpm for 5 min. The hepatocyte pellets were suspended
in 10% neutral buffered formalin and stored under

refrigeration. Immediately prior to evaluation, 1020 μL of hepatocyte suspension was mixed with
an equal volume of acridine orange (AO)–DAPI
(4´, 6-diamidino-2-phenylindole dihydrochloride)
stain solution (AO, 0.5 mg/mL; DAPI, 10 μg/mL)
for fluorescent staining. Approximately 10-20
μL of the mixture was dropped onto a glass slide
and covered with a cover glass. Samples of wellisolated hepatocytes were evaluated with the aid of
a fluorescence microscope counting the number
of MNHEPs in 2000 hepatocytes for each animal.
MNHEPs were defined as hepatocytes with round
or distinct MNs that stained like the nucleus, with
a diameter 1/4 or less than that of the nucleus, and
confirmed by focusing up and down, taking into
account hepatocyte thickness.
Statistical analysis
Biochemical and cytogenetic data were analyzed
using one-way analysis of variance (ANOVA) and
Fischer’s least significant difference (LSD) and
Duncan’s tests to determine whether any treatment
significantly differed from the controls or each
other. On the other hand, the 4 data elements are
required for the application of the Kastenbaum and
Bowman method (37). These are experimental error,
the maximum difference between treatments that is
desired to detect, a significance level, and power. With
this information, the tables provided by Bowman and
Kastenbaum were used to determine the differences
in the incidence of MNHEPs. Results presented as
mean ±SD values and the level of 0.05 was regarded
as statistically significant.
Results and discussion
Activity levels of serum marker enzymes were
found elevated markedly in rats treated with AlCl3
(Tables 1 and 2). No such changes were observed in
control rat samples. As is evident from the tables, BA
doses alone (3.25, 13, 36, and 58.5 mg/kg b.w.) did not
change the activity levels of ALP, AST, ALT, and LDH.
The pre-treatment with BA could bring a significant
decrease in the activity levels of these enzymes when
compared to AlCl3 group. Moreover, the levels of all
ALT and AST enzyme samples showed similarity
with control values after treatments together with BA
and AlCl3. The ALP (3.25 and 13 mg/kg b.w. BA) and
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Table 1. The changes in ALP and AST levels in the serum of rats treated with BA and AlCl3. Each value represents mean ± SD of 5
animals, means in the same column followed by the different letters present significant differences at the P < 0.05 level.
Treatments

ALP (U/L)

AST (U/L)

Controls

379.4 ± 41.5

a

127. 4 ± 13.9a

AlCl3 (5 mg/kg b.w.)

610.5 ± 57.9b

278.6 ± 22.4b

BA (3.25 mg/kg b.w.)

368.2 ± 46.5a

145.6 ± 16.2a

BA (13 mg/kg b.w.)

371.7 ± 34.6a

118.3 ± 14.8a

BA (36 mg/kg b.w.)

396.5 ± 42.8a

128.4 ± 12.1a

BA (58.5 mg/kg b.w.)

372.2 ± 32.7a

122.5 ± 14.8a

AlCl3 + BA (3.25 mg/kg b.w.)

405.2 ± 39.1a

114.7 ± 15.6a

AlCl3 + BA (13 mg/kg b.w.)

408.7 ± 37.6a

127.0 ± 12.7a

AlCl3 + BA (36 mg/kg b.w.)

502.9 ± 61.7b

123.5 ± 16.1a

AlCl3 + BA (58.5 mg/kg b.w.)

515.4 ± 51.6b

130.8 ± 16.4a

Table 2. The changes in ALT and LDH levels in the serum of rats treated with BA and AlCl3. Abbreviations are as in Table 1.
Treatments

ALT (U/L)

LDH (U/L)

Controls

45.2 ± 5.7a

932.8 ± 127.5a

AlCl3 (5 mg/kg b.w.)

75.5 ± 8.2b

1350.7 ± 214.6b

BA (3.25 mg/kg b.w.)

49.4 ± 5.8a

932.2 ± 125.6a

BA (13 mg/kg b.w.)

45.0 ± 6.1a

1015.5 ± 142.7a

BA (36 mg/kg b.w.)

39.7 ± 4.8a

1026.4 ± 155.8a

BA (58.5 mg/kg b.w.)

44.4 ± 5.1a

1030.3 ± 148.6a

AlCl3 + BA (3.25 mg/kg b.w.)

39.3 ± 4.5a

980.1 ± 133.0a

AlCl3 + BA (13 mg/kg b.w.)

37.1 ± 4.6a

1190.8 ± 172.8b

AlCl3 + BA (36 mg/kg b.w.)

42.3 ± 5.5a

1225.6 ± 189.8b

AlCl3 + BA (58.5 mg/kg b.w.)

45.8 ± 6.0a

1264.6 ± 211.4b

LDH (3.25 mg/kg b.w. BA) enzyme activities were
normalized by low doses of BA exposure, Our results
clearly revealed that BA presented useful effects on
the activities of enzymes as directly related to the
dose for LDH and ALP and without depending on
dose for ALT and AST against AlCl3-induced liver
damages.
The conclusions of the present study reveal that
BA inhibits the leakage of liver marker enzymes into
circulation and, therefore, limits the damages caused
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by AlCl3 toxicity. In the past, no proof was available
to support these data. It is known that the swelling
and necrosis of hepatocytes results in the release of
liver enzymes into the circulating blood (38). This
was associated with massive centrilobular necrosis,
ballooning degeneration, and cellular infiltration
of the liver (39). The chemicals as Al induce these
findings (40,41) and overall perturbations observed
in the metabolic profile of serum demonstrate the
impairment in the liver metabolism (42). Rahman
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et al. (43) reported that the increase in the activities
of different enzymes in blood might be due to the
necrosis of liver, this showing the stress condition
of the treated animals. At this point, our study
clearly supports that liver damage is induced by Al
administration. As a matter of fact, the elevation in
transaminase is encountered in conditions causing
hepatocellular damage, loss of functional integrity
of the cell membrane, and necrosis such as in
chemically induced liver injury and elevation in
enzymes (44,45). Thus, it will be relevant to briefly
mention the importance of enzymic changes as
manifestations of tissue toxicity. Elevations are seen
in the liver and myocardial injury, and a rise in serum
AST and ALT is more specific and predominant in
the liver and myocardial injury, respectively. The
modulations in transaminase are also influenced by
the degree of hepatic decompensation of cell necrosis
(46). A significant increase in ALP could occur in
parenchymal liver disorders such as hepatitis and
cirrhosis, and striking elevation is encountered with
extrahepatic biliary tract (mechanical) obstruction or
with intrahepatic (functional cholestasis) (47). Again,
the LDH in serum as a biological marker for liver
damage increases (48). Cell necrosis leads to a rise in
the concentration of the LDH enzyme in serum and
tissue. The LDH released into the medium provides
an index of cell death and membrane permeability to
LDH, and an increase in LDH activity in the medium
occurs as a result of cell membrane disintegration
and enzyme leakage (49-51). The present study also
demonstrates that AlCl3 significantly affects LDH
level in serum. The evidence reveals that the activities
of LDH are used as a marker of Al toxicity (52).
Thus, it is obvious that the increase in degenerative
effects of AlCl3 becomes more prominent with the
increase in the LDH level. Results from previous
investigations indicate that BA does not affect liver
weight and histology (53). Our study also reveals that
hepatocytes retain their capacity to normal function
after BA alone exposures. Moreover, BA against Al
presents useful effects on the activities of enzymes
as directly related to the dose (LDH and ALP) or
without depending on dose (ALT and AST).
No single mechanism emerges to explain all the
systemic effects of Al. One of the mechanisms involves
free radical-induced oxidative cell injury in Al
toxicity (52). As a matter of fact, interactions between

oxidative stress and hepatic damage may accelerate
the progression of chronic hepatodegenerative
disorders, including enzymes increase induced by Al
(10,42). In contrast, increasing antioxidant capacity
plays an important role as a hepatoprotective (54).
Therefore, there is great interest in the clinical roles
of BA. It is noteworthy that even in small amounts
BA helps protect nucleic acids from damage by
free radicals and reactive oxygen species that can
be generated during normal metabolism as well as
through exposure to toxins and pollutants (23,55).
However, it should be noted that boron itself is not
an antioxidant, but is reported to strengthen the
antioxidant defense system of the tissues (56,57).
Al has high affinity for proteins, carbohydrates,
and polynucleotides and may exist as a reversible
macromolecular complex of cation/polyanion.
If the cation/polyanion ratio exceeds a threshold
value, an irreversible complex can be formed, giving
rise to inhibitory effect of Al. Once in the liver, Al
increases cells’ iron uptake and oxidative status (58).
The liver is the chief site of iron storage, containing
98% of total iron and a large abundance of transferrin
receptors (TfRs). Thus, it produces toxic effects by
modifying iron homeostasis and interfering with
iron regulatory proteins (59). BA does not affect the
parameters of carbohydrate and protein metabolism
(60). Besides, BA can protect biomembranes (56).
On the other hand, Al-induced polynuclear ions
can also produce membrane changes and aggregate
biomolecules (61). Again, the chemicals such as Al
induce the process of lipid peroxidation in the cell
membrane (62), a principal cause of hepatotoxicity
(63). Lipid peroxidation is linked with the excess
generation of reactive oxygen species, which may
be contributed to by exogenous or the endogenous
sources. Boron (as borax) can help to maintain the
oxidant/antioxidant balance of the liver as a result of
the decreased generation of lipid peroxidation (12).
Additionally, Al intake inflicts membrane associated
proteins (Na-K ATPase, and PKC) (64). In contrast,
it has been proposed that boron contributes to living
systems by acting indirectly as a proton donor and
that it exerts an influence on cell membrane structure
and function (65). Although the absolute essentiality
of boron for plants is well documented, studies to
date have not shown it to be unequivocally essential
for either animals or humans.
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Table 3 shows the results of the liver MN assay
in Sprague-Dawley rats. AlCl3 induced a statistically
significant increase in formations of MNHEPs
although BA did not cause any alterations dependent
upon the number of doses administered. Moreover,
BA (3.25 and 13 mg/kg b.w.) modulated the increased
MNHEPs rates by AlCl3 (Figure 1A, B, and C).

(III) bone marrow is not a target organ for some
classes of carcinogens (21). Thus, in the present study,
we assessed the liver MN assay. The results of in vitro
studies in mammalian and bacterial systems have not
revealed mutagenic effects of aluminum compounds
(67,68) although some genotoxicity studies have
shown significant increases in MN formations
and structural chromosome aberrations in human
lymphocytes by Al (7,9,69). Manna and Das (70)
reported the genotoxic effects of intraperitoneally
injected aluminum chloride in mice. Agency
for Toxic Substances and Disease Registry (71)
also suggested that further genotoxicity studies,
particularly in vivo exposures of Al, would be useful
for verifying the results of the Manna and Das (70)

The bone marrow and liver MN assays were
recommended for evaluating systemic genetic
toxicity of chemicals (66). Using the liver instead
of the bone marrow is important for the following
reasons: (I) many chemicals are metabolized in the
liver but not in the bone marrow, (II) short-lived
metabolites generated in the liver (or other tissue)
may not allow efficient exposure in bone marrow,

Table 3. Results of the liver MN assay in rats treated with AlCl3 and BA. HEP, hepatocyte; means in the same column followed by the
different letters present significant differences at the P < 0.05 level
No. of animals

MNHEP (%)/2000 HEP, mean ± standard
deviation

Controls

5

0.38 ± 0.08a

AlCl3 (5 mg/kg b.w.)

5

0.94 ± 0.51c

BA (3.25 mg/kg b.w.)

5

0.30 ± 0.17a

BA (13 mg/kg b.w.)

5

0.35 ± 0.20a

BA (36 mg/kg b.w.)

5

0.53 ± 0.28ab

BA (58.5 mg/kg b.w.)

5

0.49 ± 0.22ab

AlCl3 + BA (3.25 mg/kg b.w.)

5

0.43 ± 0.19a

AlCl3 + BA (13 mg/kg b.w.)

5

0.51 ± 0.24ab

AlCl3 + BA (36 mg/kg b.w.)

5

0.82 ± 0.37bc

AlCl3 + BA (58.5 mg/kg b.w.)

5

1.04 ± 0.58c

Treatments

Figure 1. Sample photomicrographs of hepatocytes treated with (A) BA (13 mg/kg b.w.), (B) AlCl3 (5 mg/kg b.w.) and (C) AlCl3 +
BA (58.5 mg/kg b.w.). Arrows show micronuclei. The cells were stained with AO-DAPI and viewed with epiluminescent
fluorescent lighting; ×1000.
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study and for evaluating other potential end points
of genotoxicity. At this point, the findings of our
study support the limited in vivo reports. As a matter
of fact, it is established that a significant increase
in the rates of MNHEPs occurs after in vivo Al
exposure. It is also determined that that BA exhibits
antigenotoxic properties against AlCl3. Existing data
suggest that genotoxicity is not an area of concern
following exposure to boron compounds in humans
and animals (72). Likewise, negative results in a large
number of in vitro and in vivo mutagenicity assays
indicate that boron compounds, especially boric
acid and borax, are not genotoxic (23,24,25,55).
Furthermore, recent findings show that these
compounds exhibit anti-oxidant and anti-genotoxic
properties against toxic chemicals including titanium
and thioacetamide (12,55). Very little is known about
the biological effects of boron exposure in animal
cells (73). Although the physiological function of
the boron in hepatocytes is unknown, a hypothesis is
that Al-induced genetic damage can be prevented by
inductive effects of boron compounds on antioxidant
capacity, because the toxic effects of Al appear to be
mediated, at least in part, by free radicals (74). As
known, genetic damage mainly develops related to
oxidative stress.

It is noteworthy that the toxic effect of Al on
human health cannot be ruled out either, and thus
exposure to Al should be monitored and limited.
Foremost, the detrimental effects of Al as a risk factor
for developing tissue damages should be decreased as
far as possible. In the present study, the boron-related
remedy was especially important against aluminuminduced hepatic dysfunction and genetic damage.
Thus, BA can be firstly proposed to prevent Al
toxicity as a nutritional supplement or a functional
food component.
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